Clinical Trial Update: Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma

View source ↗

Summary

This University of Kansas–sponsored study on circulating tumor cells and circulating endothelial cells in renal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: University of Kansas | Conditions: Renal Cell Carcinoma | Status: COMPLETED